Vanguard Group’s NCI, Inc. NCIT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2017
Q3 | – | Sell |
-296,922
| Closed | -$6.26M | – | 4107 |
|
|
2017
Q2 | $6.26M | Sell |
296,922
-4,475
| -1% | -$76.8K | ﹤0.01% | 3002 |
|
|
2017
Q1 | $4.54M | Buy |
301,397
+10,151
| +3% | +$143K | ﹤0.01% | 3090 |
|
|
2016
Q4 | $4.06M | Buy |
291,246
+2,162
| +0.7% | +$27.3K | ﹤0.01% | 3139 |
|
|
2016
Q3 | $3.34M | Buy |
289,084
+40,334
| +16% | +$504K | ﹤0.01% | 3183 |
|
|
2016
Q2 | $3.5M | Buy |
248,750
+12,449
| +5% | +$171K | ﹤0.01% | 3150 |
|
|
2016
Q1 | $3.31M | Buy |
236,301
+21,853
| +10% | +$297K | ﹤0.01% | 3170 |
|
|
2015
Q4 | $2.93M | Buy |
214,448
+8,993
| +4% | +$134K | ﹤0.01% | 3237 |
|
|
2015
Q3 | $2.73M | Buy |
205,455
+16,515
| +9% | +$208K | ﹤0.01% | 3231 |
|
|
2015
Q2 | $1.95M | Buy |
188,940
+2,430
| +1% | +$25.5K | ﹤0.01% | 3433 |
|
|
2015
Q1 | $1.87M | Buy |
186,510
+13,800
| +8% | +$156K | ﹤0.01% | 3440 |
|
|
2014
Q4 | $1.76M | Buy |
172,710
+600
| +0.3% | +$6.32K | ﹤0.01% | 3331 |
|
|
2014
Q3 | $1.64M | Buy |
172,110
+1,100
| +0.6% | +$10.3K | ﹤0.01% | 3346 |
|
|
2014
Q2 | $1.52M | Hold |
171,010
| – | – | ﹤0.01% | 3367 |
|
|
2014
Q1 | $1.82M | Buy |
171,010
+13,200
| +8% | +$122K | ﹤0.01% | 3262 |
|
|
2013
Q4 | $1.04M | Hold |
157,810
| – | – | ﹤0.01% | 3400 |
|
|
2013
Q3 | $889K | Buy |
157,810
+3,940
| +3% | +$20.1K | ﹤0.01% | 3404 |
|
|
2013
Q2 | $637K | Buy |
+153,870
| New | +$694K | ﹤0.01% | 3420 |
|
Vanguard Group's NCIT Position: Q3 2017 in Review
Vanguard Group sold out of NCI, Inc. (NCIT) in Q3 2017, closing a stake of 296,922 shares — an estimated $6.26M sold.
Vanguard Group first reported a position in NCIT in Q2 2013 and held it in 17 quarters. The position peaked at $6.26M in Q2 2017. 0 funds tracked by Wall St. Rank hold NCIT as of Q3 2017.
- Vanguard Group reported no remaining NCI, Inc. position as of Q3 2017 after selling out during the quarter.
- Vanguard Group sold 296,922 NCI, Inc. shares in Q3 2017, an estimated $6.26M.
- Vanguard Group first reported a position in NCI, Inc. in Q2 2013 and held it in 17 quarters.
- Vanguard Group's NCI, Inc. position peaked at $6.26M in Q2 2017.
- 0 funds tracked by Wall St. Rank held NCI, Inc. as of Q3 2017.
Based on Vanguard Group's 13F filing for Q3 2017, filed 14 Nov 2017.